<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01089959</url>
  </required_header>
  <id_info>
    <org_study_id>ISS Astra Zeneca 7 day Nexium</org_study_id>
    <nct_id>NCT01089959</nct_id>
  </id_info>
  <brief_title>Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD</brief_title>
  <acronym>ISS</acronym>
  <official_title>The Effect of Esomeprazole 40 mg. Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With Gastroesophageal Reflux Disease (GERD).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern Arizona VA Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern Arizona VA Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if esomeprazole 40 mg. once daily improves not only
      nighttime symptoms but also significantly reduces conscious awakenings associated with
      gastroesophageal reflux and consequently improves sleep quality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty GERD patients with nighttime heartburn and/or regurgitation at least 3 times a week
      will be invited to participate in the study. All patients will undergo upper endoscopy to
      determine presence or absence of esophageal inflammation(using Los Angeles criteria). All
      patients will be evaluated by the Demographic,Berlin,Epworth Sleepiness Scale Questionnaires,
      and GERD Symptom Checklist. Thereafter,patients will undergo pH testing w/ an actigraph.The
      morning of pH probe removal,a Sleep Quality Questionaire will be administered.

      Subjects will then receive esomeprazole 40 mg. once daily(30 minutes before breakfast) for 1
      week. On day 7,subjects will again undergo pH testing w/ actigraphy, and the results will be
      analyzed again w/ new integrative software. On the morning of pH probe removal, the sleep
      Quality Questionnaire will be re-administered.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Effect of Esomeprazole 40 mg. Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients w/ GERD.</measure>
    <time_frame>2 years</time_frame>
    <description>This is the first study to evaluate the impact of antireflux treatment, not only on heartburn during sleep, but also on reflux-related conscious awakenings.
This has not been done previously and will thus provide an opportunity to assess the impact of esomeprazole on nighttime symptoms and awakenings.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Esomeprazole</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Effect of PPI esomeprazole on acid reflux &amp; related arousals during sleep in patients with GERD.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esomeprazole</intervention_name>
    <description>40 mg daily for 7 days</description>
    <arm_group_label>Esomeprazole</arm_group_label>
    <other_name>Nexium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>esomeprazole</intervention_name>
    <description>40 mg. daily, oral medication, once daily for 7 days.</description>
    <arm_group_label>Esomeprazole</arm_group_label>
    <other_name>Nexium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nocturnal symptoms at least twice a week.

          -  Ages 18-80

          -  Erosive esophagitis and/or abnormal pH test -

          -  Able to read, understand, and complete study questionnaires

        Exclusion Criteria:

          -  Subjects with Barrett's esophagus or peptic stricture on endoscopy

          -  Subjects with normal endoscopy and pH test

          -  Subjects with previous upper gastrointestinal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronnie Fass, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SAVAHCS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>RONNIE FASS, MD</last_name>
    <phone>520-792-1450</phone>
    <phone_ext>5139</phone_ext>
    <email>ronniefass@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MARCIA R WILLIS, CCRC</last_name>
    <phone>520-792-1450</phone>
    <phone_ext>2032</phone_ext>
    <email>marcia.willis@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southern Arizona VA Health Care System</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronnie Fass, MD</last_name>
      <phone>520-792-1450</phone>
      <phone_ext>5139</phone_ext>
      <email>ronniefass@va.gov</email>
    </contact>
    <investigator>
      <last_name>RONNIE FASS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2010</study_first_submitted>
  <study_first_submitted_qc>March 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2010</study_first_posted>
  <last_update_submitted>August 18, 2010</last_update_submitted>
  <last_update_submitted_qc>August 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>RONNIE FASS M.D.</name_title>
    <organization>SOUTHERN AZ. VA HEALTH CARE SYSTEM</organization>
  </responsible_party>
  <keyword>Acid re-flux,GERD</keyword>
  <keyword>sleep related arousals due to GERD</keyword>
  <keyword>Treatment of acid reflux during sleep in patients with GERD.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Heartburn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esomeprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

